# CARTx Therapeutics

Source: https://onco.cc/companies/cartx-therapeutics/  
OnCo record `cartx-therapeutics` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

CARTx Therapeutics, spun out of Nationwide Children's Hospital, is developing affordable off-the-shelf CAR gamma-delta T cell therapies from healthy donors for solid tumours and blood cancers.

## Summary

CARTx Therapeutics uses polyclonal gamma-delta T cells from healthy donors, engineered with chimeric antigen receptors, to make allogeneic cell therapies that do not need to be manufactured from each patient, aiming at lower cost and faster access for solid tumours and blood cancers.

## Fields

- Kind: Company
- Last checked: 2026-09-11
- Tags: ctgov-sponsor; fcct-directory
- HQ: United States (city not published)
- Type: cell-therapy
- Website: https://www.cartx.health/

## Sources

- Official website: https://www.cartx.health/
- Listed on Future of Cancer Care Today (Sijbrandij Foundation): https://sijbrandijfoundation.org/fcct

## Connected records

- technologies: [CAR-T cell therapy](https://onco.cc/technologies/car-t/), [Gamma-delta T cell therapy](https://onco.cc/technologies/gamma-delta-t-cell-therapy/)

---
JSON: https://onco.cc/api/v1/entities/cartx-therapeutics.json